Indian Journal of Endocrine Surgery and Research

Register      Login

VOLUME 19 , ISSUE 1 ( January-June, 2024 ) > List of Articles

CASE REPORT

Exploring the Extraordinary: Unusual Hematopoietic Malignancies of Thyroid Gland

Rohit Singh, Chanchal Rana, M Shreyamsa, Pooja Ramakant, Anand Kumar Mishra

Keywords : Case report, Langerhans cell histiocytosis, Plasmacytoma, T-cell lymphoma, Thyroid diseases, Thyroid neoplasms

Citation Information : Singh R, Rana C, Shreyamsa M, Ramakant P, Mishra AK. Exploring the Extraordinary: Unusual Hematopoietic Malignancies of Thyroid Gland. 2024; 19 (1):21-25.

DOI: 10.5005/jp-journals-10088-11235

License: CC BY-NC 4.0

Published Online: 17-06-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Thyroid disorders encompass a broad spectrum of pathological conditions, the majority of which are benign and also include autoimmune thyroiditis, multinodular goiter, and papillary thyroid carcinoma. However, some thyroid pathologies are unusual and pose diagnostic and management challenges. This study discusses the presentation, diagnostic challenges, and management of these rare presentations and tumors, as seen in our institution. First patient with primary T-cell lymphoma of the thyroid, an exceedingly rare malignancy accounting for a minute fraction of thyroid neoplasms. Second patient highlights an uncommon case of solitary extramedullary plasmacytoma of the thyroid, constituting less than 1% of all extramedullary plasmacytomas. Third patient portrays Langerhans cell histiocytosis (LCH) of the thyroid, an unusual entity often presenting diagnostic complexities due to its rarity and association with other thyroid pathologies. These cases emphasize the rarity of these thyroid pathologies and the need for a comprehensive approach to diagnosis and management. Tailored treatment strategies are necessary, taking into account the clinical presentation and extent of the disease. Due to the limited data available for these rare pathologies, further research and comprehensive reporting are crucial for refining our understanding and optimizing treatment strategies. In conclusion, these cases exemplify the diagnostic and management challenges posed by unusual thyroid pathologies and underscore the importance of accurate diagnosis and a multidisciplinary approach to manage these rare conditions effectively.


PDF Share
  1. Osada de la Paz M, Villaverde-Hueso A, Alonso V, et al. Rare diseases epidemiology research. In: Posada de la Paz M, Groft SC, editors. Rare diseases epidemiology. London, New York: Springer Dordrecht Heidelberg; 2010. pp. 17–40.
  2. Hennekam RC. Care for patients with ultra-rare disorders. Eur J Med Genet 2011;54(3):220–224. DOI: 10.1016/j.ejmg.2010.12.001.
  3. Hunt JL. Unusual thyroid tumors: A review of pathologic and molecular diagnosis. Expert Rev Mol Diagn 2005;5(5):725–734. DOI: 10.1586/14737159.5.5.725.
  4. Walsh S, Lowery AJ, Evoy D, et al. Thyroid lymphoma: Recent advances in diagnosis and optimal management strategies. Oncologist 2013;18(9):994–1003. DOI: 10.1634/theoncologist.2013- 0036.
  5. Mishra P, Banerjee D, Gujral S. T-cell lymphoma of thyroid gland with lennert type of morphology: A case report and review of the literature. Head Neck Pathol 2016;10(3):321–326. DOI: 10.1007/s12105-016-0711-z.
  6. Watanabe N, Noh JY, Narimatsu H, et al. Clinicopathological features of 171 cases of primary thyroid lymphoma: A long-term study involving 24 553 patients with Hashimoto's disease. Br J Haematol 2011;153(2):236–243. DOI: 10.1111/j.1365-2141.2011.08606.x.
  7. Hassan MJ, Khans S, Pujani M, et al. Extramedullary plasmacytoma of the thyroid: Report of a rare case. Blood Res 2014;49(4):280–283. DOI: 10.5045/br.2014.49.4.280.
  8. Wiltshaw E. The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine (Baltimore) 1976;55:217–238. DOI: 10.1097/00005792-197605000-00002.
  9. Hazard JB, Schildecker WW. Plasmacytoma of the thyroid. Am J Pathol 1949;25(Suppl):819–820.
  10. Macpherson TA, Dekker A, Kapadia SB. Thyroid-gland plasma cell neoplasm (plasmacytoma) Arch Pathol Lab Med 1981;105: 570–572. PMID: 7027992.
  11. Aozasa K, Inoue A, Yoshimura H, et al. Plasmacytoma of the thyroid gland. Cancer 1986;58:105–110. DOI: 10.1002/1097-0142(19860701) 58:1<105::aid-cncr2820580119>3.0.co;2-k.
  12. Galieni P, Cavo M, Pulsoni A, et al. Clinical outcome of extramedullary plasmacytoma. Haematologica 2000;85:47–51. PMID: 10629591.
  13. Ridal M, Ouattassi N, Harmouch T, et al. Solitary extramedullary plasmacytoma of the thyroid gland. Case Rep Otolaryngol 2012;2012:282784. DOI: 10.1155/2012/282784.
  14. Bhat V, Shariff S, Reddy RAN. Extramedullary plasmacytoma of thyroid – A mimicker of medullary carcinoma at fine needle aspiration cytology: A case report. J Cytol 2014;31(1):53–56. DOI: 10.4103/0970-9371.130710.
  15. Caers J, Paiva B, Zamagni E, et al. Diagnosis, treatment, and response assessment in solitary plasmacytoma: Updated recommendations from a European Expert Panel. J Hematol Oncol J Hematol Oncol 2018;11(1):10. DOI: 10.1186/s13045-017-0549-1.
  16. Kilciksiz S, Karakoyun-Celik O, Agaoglu FY, et al. A review for solitary plasmacytoma of bone and extramedullary plasmacytoma. Sci World J 2012;2012:895765. DOI: 10.1100/2012/895765.
  17. Layfield LJ, Kakudo K. Metastatic tumors, lymphomas, and rare tumors of the thyroid. Bethesda Syst Report Thyroid Cytopathol 2018;205–230.
  18. Braiteh F, Kurzrock R. Langerhans cell histiocytosis of the thyroid. J Clin Oncol 2006;24(3):522–523.
  19. Patten DK, Wani Z, Tolley N. Solitary Langerhans histiocytosis of the thyroid gland: A case report and literature review. Head Neck Pathol 2011;6(2):279–289. DOI: 10.1007/s12105-011-0321-8.
  20. Wu X, Chen S, Zhang LY, et al. Langerhans cell histiocytosis of the thyroid complicated by papillary thyroid carcinoma: A case report and brief literature review. Medicine (Baltimore) 2017;96(35):e7954. DOI: 10.1097/MD.0000000000007954.
  21. Ceyran AB, Senol S, Bayraktar B, et al. Langerhans cell histiocytosis of the thyroid with multiple cervical lymph node involvement accompanying metastatic thyroid papillary carcinoma. Case Rep Pathol 2014;2014:184237. DOI: 10.1155/2014/184237.
  22. Diego E, Biagetti B, Iglesias C, et al. Histiocitosis de células de Langerhans asociada a carcinoma papilar de tiroides. Rev Clínica Esp 2014;214(2):e19–e21. DOI: 10.1016/j.rce.2013.11.005.
  23. Chakraborty R, Hampton OA, Shen X, et al. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood 2014;124(19):3007–3015. DOI: 10.1182/blood-2014-05-577825.
  24. Saqi A, Kuker AP, Ebner SA, et al. Langerhans cell histiocytosis: Diagnosis on thyroid aspirate and review of the literature. Head Neck Pathol 2015;9(4):496–502. DOI: 10.1007/s12105-015-0608-2.
  25. Pusztaszeri MP, Sauder KJ, Cibas ES, et al. Fine-needle aspiration of primary Langerhans cell histiocytosis of the thyroid gland, a potential mimic of papillary thyroid carcinoma. Acta Cytol 2013;57(4):406–412. DOI: 10.1159/000348801.
  26. Girschikofsky M, Arico M, Castillo D, et al. Management of adult patients with Langerhans cell histiocytosis: Recommendations from an expert panel on behalf of Euro-Histio-Net. Orphanet J Rare Dis 2013;8:72. DOI: 10.1186/1750-1172-8-72.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.